International Stem Cell Corp (ISCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,191 | -6,172 | -10,600 | -7,773 | -7,481 |
| Depreciation Amortization | 204 | 134 | 67 | 273 | 196 |
| Accounts receivable | -54 | -176 | -29 | -49 | -43 |
| Accounts payable and accrued liabilities | -140 | -88 | 192 | -56 | 387 |
| Other Working Capital | -454 | -508 | 76 | 43 | 609 |
| Other Operating Activity | 4,114 | 2,931 | 8,844 | 2,333 | 2,785 |
| Operating Cash Flow | $-5,522 | $-3,878 | $-1,450 | $-5,228 | $-3,547 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -245 | -197 | -67 | -731 | -650 |
| Purchase Sale Intangibles | -255 | -160 | -65 | -159 | -118 |
| Other Investing Activity | -255 | -160 | -65 | -159 | -118 |
| Investing Cash Flow | $-500 | $-358 | $-132 | $-890 | $-768 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 200 | N/A | N/A |
| Common Stock Issued | 8,962 | 8,836 | 867 | 1,494 | 1,319 |
| Dividend Paid | -120 | -106 | -106 | -331 | N/A |
| Other Financing Activity | 2,411 | 2,411 | 2,411 | 5,300 | 3,000 |
| Financing Cash Flow | $11,253 | $11,140 | $3,372 | $6,463 | $4,319 |
| Beginning Cash Position | 727 | 727 | 727 | 382 | 382 |
| End Cash Position | 5,958 | 7,631 | 2,517 | 727 | 387 |
| Net Cash Flow | $5,231 | $6,905 | $1,790 | $345 | $5 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,522 | -3,878 | -1,450 | -5,228 | -3,547 |
| Capital Expenditure | -245 | -197 | -67 | -731 | -650 |
| Free Cash Flow | -5,767 | -4,075 | -1,517 | -5,959 | -4,197 |